206 related articles for article (PubMed ID: 25837430)
1. Evaluation of crystallographic orientation of biological apatite in vertebral cortical bone in ovariectomized cynomolgus monkeys treated with minodronic acid and alendronate.
Tanaka M; Matsugaki A; Ishimoto T; Nakano T
J Bone Miner Metab; 2016 Mar; 34(2):234-41. PubMed ID: 25837430
[TBL] [Abstract][Full Text] [Related]
2. Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys.
Mashiba T; Saito M; Yamagami Y; Tanaka M; Iwata K; Yamamoto T
Bone; 2017 Apr; 97():184-191. PubMed ID: 28082077
[TBL] [Abstract][Full Text] [Related]
3. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
Tanaka M; Mori H; Kawabata K; Mashiba T
Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
[TBL] [Abstract][Full Text] [Related]
4. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
[TBL] [Abstract][Full Text] [Related]
5. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
[TBL] [Abstract][Full Text] [Related]
6. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
7. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
8. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
Bone; 2016 May; 86():43-52. PubMed ID: 26921823
[TBL] [Abstract][Full Text] [Related]
9. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
[TBL] [Abstract][Full Text] [Related]
10. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey.
Müller R; Hannan M; Smith SY; Bauss F
J Bone Miner Res; 2004 Nov; 19(11):1787-96. PubMed ID: 15476578
[TBL] [Abstract][Full Text] [Related]
11. Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosis.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Yamada H; Kawada N; Kawabata K
Calcif Tissue Int; 2014 Aug; 95(2):166-73. PubMed ID: 24903232
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
Iwamoto J; Seki A; Sato Y
Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
[TBL] [Abstract][Full Text] [Related]
13. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate.
Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T
J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245
[TBL] [Abstract][Full Text] [Related]
14. Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.
Duong LT; Pickarski M; Cusick T; Chen CM; Zhuo Y; Scott K; Samadfam R; Smith SY; Pennypacker BL
Bone; 2016 Jul; 88():113-124. PubMed ID: 27126999
[TBL] [Abstract][Full Text] [Related]
15. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys.
Kostenuik PJ; Smith SY; Samadfam R; Jolette J; Zhou L; Ominsky MS
J Bone Miner Res; 2015 Apr; 30(4):657-69. PubMed ID: 25369992
[TBL] [Abstract][Full Text] [Related]
16. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
17. Effect of concurrent administration of alendronate sodium and retinol on development of changes in histomorphometric parameters of bones induced by ovariectomy in rats.
Pytlik M; Kaczmarczyk-Sedlak I; Sliwiński L; Janiec W; Rymkiewicz I
Pol J Pharmacol; 2004; 56(5):571-9. PubMed ID: 15591645
[TBL] [Abstract][Full Text] [Related]
18. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys.
Hotchkiss CE; Stavisky R; Nowak J; Brommage R; Lees CJ; Kaplan J
Bone; 2001 Jul; 29(1):7-15. PubMed ID: 11472885
[TBL] [Abstract][Full Text] [Related]
19. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.
Cho DC; Kim KT; Jeon Y; Sung JK
Acta Neurochir (Wien); 2012 Dec; 154(12):2215-23. PubMed ID: 23053289
[TBL] [Abstract][Full Text] [Related]
20. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
